Department of Public Health Sciences, Senior ICES Scientist, Queen's University, Kingston, ON, Canada.
Department of Anesthesiology and Perioperative Medicine, Kingston Health Sciences Centre, Queen's University, 76 Stuart Street, Kingston, ON, K7L 2V7, Canada.
Can J Anaesth. 2022 Aug;69(8):963-973. doi: 10.1007/s12630-022-02240-1. Epub 2022 Mar 22.
Postoperative opioid use may be associated with increased healthcare utilization and costs. We sought to examine the relationship between duration of postoperative opioid prescriptions and healthcare costs and resource utilization in senior patients following hip and knee replacement.
We conducted a historical cohort study evaluating postoperative opioid use and healthcare costs in patients over the age of 65 yr undergoing primary total hip or knee arthroplasty over a ten-year period from 1 April 2006 to 31 March 2016. The last follow-up date was 31 March 2017. We identified preoperative and postoperative opioid prescriptions, patient characteristics, and healthcare costs using deidentified Ontario administrative databases (Institute of Clinical Evaluative Sciences). Duration of postoperative opioid use was divided into four categories: short-term (1-90 days), prolonged (91-180 days), chronic (181-365 days), and undocumented.
The study included 49,638 hip and 85,558 knee replacement patients. Although the initial hospitalization accounted for the greatest cost in all patients, over the following year patients in the short-term opioid use group incurred the lowest average costs, and those in the chronic group incurred the highest (hip, CAD 17,528 vs CAD 26,736; knee, CAD 16,043 vs CAD 23,007), driven by increased healthcare resource utilization.
Chronic opioid use after arthroplasty was associated with higher resource utilization and healthcare costs during the year following surgery. These results can be used to develop predictors of longer opioid use and higher costs. Further research is planned to determine whether recently implemented opioid reduction strategies can reduce healthcare resource utilization.
术后阿片类药物的使用可能与增加医疗保健利用和成本有关。我们旨在研究髋膝关节置换术后老年患者术后阿片类药物处方持续时间与医疗保健成本和资源利用之间的关系。
我们进行了一项回顾性队列研究,评估了 2006 年 4 月 1 日至 2016 年 3 月 31 日十年间 65 岁以上接受初次全髋关节或全膝关节置换术的患者的术后阿片类药物使用和医疗保健成本。最后一次随访日期为 2017 年 3 月 31 日。我们使用匿名安大略省行政数据库(临床评估科学研究所)识别术前和术后阿片类药物处方、患者特征和医疗保健成本。术后阿片类药物使用持续时间分为四类:短期(1-90 天)、延长(91-180 天)、慢性(181-365 天)和未记录。
该研究纳入了 49638 例髋关节置换和 85558 例膝关节置换患者。尽管所有患者最初的住院治疗费用最高,但在接下来的一年中,短期阿片类药物使用组的患者平均成本最低,而慢性阿片类药物使用组的患者成本最高(髋关节,CAD17528 比 CAD26736;膝关节,CAD16043 比 CAD23007),这是由于医疗资源利用增加所致。
关节置换术后慢性阿片类药物使用与术后一年的资源利用和医疗保健成本增加有关。这些结果可用于开发预测长期阿片类药物使用和更高成本的指标。计划进行进一步研究,以确定最近实施的减少阿片类药物策略是否可以减少医疗资源的利用。